Unique Wealth Strategies LLC Purchases Shares of 12,638 Corteva, Inc. (NYSE:CTVA)

Unique Wealth Strategies LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 12,638 shares of the company’s stock, valued at approximately $606,000.

Several other hedge funds have also bought and sold shares of the stock. Union Savings Bank boosted its stake in shares of Corteva by 58.5% in the third quarter. Union Savings Bank now owns 577 shares of the company’s stock worth $30,000 after acquiring an additional 213 shares during the period. Essex Financial Services Inc. boosted its stake in shares of Corteva by 3.2% in the third quarter. Essex Financial Services Inc. now owns 6,883 shares of the company’s stock worth $352,000 after acquiring an additional 215 shares during the period. NewSquare Capital LLC boosted its stake in shares of Corteva by 70.6% in the third quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock worth $28,000 after acquiring an additional 226 shares during the period. Tradewinds LLC. boosted its stake in shares of Corteva by 5.1% in the third quarter. Tradewinds LLC. now owns 4,788 shares of the company’s stock worth $245,000 after acquiring an additional 231 shares during the period. Finally, Jeppson Wealth Management LLC boosted its stake in shares of Corteva by 6.2% in the third quarter. Jeppson Wealth Management LLC now owns 4,300 shares of the company’s stock worth $220,000 after acquiring an additional 250 shares during the period. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.4 %

NYSE CTVA traded up $0.22 during midday trading on Friday, hitting $54.92. 2,350,151 shares of the company traded hands, compared to its average volume of 2,425,831. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.56 and a quick ratio of 0.90. The company has a market cap of $38.38 billion, a PE ratio of 53.84, a price-to-earnings-growth ratio of 1.44 and a beta of 0.77. The company’s 50-day simple moving average is $55.28 and its 200-day simple moving average is $50.46. Corteva, Inc. has a 52 week low of $43.22 and a 52 week high of $61.87.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.06 by $0.09. The business had revenue of $3.71 billion for the quarter, compared to analysts’ expectations of $3.54 billion. Corteva had a return on equity of 7.43% and a net margin of 4.27%. During the same quarter last year, the firm earned $0.16 EPS. As a group, equities research analysts forecast that Corteva, Inc. will post 2.84 earnings per share for the current year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th will be given a dividend of $0.16 per share. The ex-dividend date is Tuesday, June 4th. This represents a $0.64 annualized dividend and a yield of 1.17%. Corteva’s dividend payout ratio (DPR) is presently 62.75%.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on CTVA. Barclays upped their price objective on Corteva from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 10th. TheStreet raised Corteva from a “c+” rating to a “b-” rating in a research note on Tuesday, February 27th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $57.00 price target (down from $58.00) on shares of Corteva in a research note on Friday, April 12th. UBS Group dropped their price target on Corteva from $65.00 to $64.00 and set a “buy” rating for the company in a research note on Thursday, January 11th. Finally, KeyCorp increased their price target on Corteva from $63.00 to $66.00 and gave the company an “overweight” rating in a research note on Tuesday, April 9th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $63.29.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.